CLINICAL_TRIALS trial_result · 2022-07-26

Clinical Trial Update: Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder [Phase 3]

Phase 3 trial evaluating adjunctive ganaxolone in children and young adults with CDKL5 deficiency disorder has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Marinus Pharmaceuticals | Conditions: CDKL5 Deficiency Disorder | Phase 3 | Status: COMPLETED | Results posted: 2022-07-26